Erwann Loret
ETRAV laboratory (Aix Marseille University/CNRS), France
Biography
He obtained Ph. D. in France, then he went to USA in 1990 for a first post-doc in the department of biophysics and biochemistry at Oregon State University, followed by a second post-doc in 1992 in the department of chemistry at the University of California, Davis. He was recruited as full senior scientist in 1992 in CNRS (Centre National de la Recherche Scientifique), which is the main French national agency for scientific research. Erwann Loret obtained the GlaxoSmith Kline Drug Discovery and Development Award from an American scientific committee for his contribution to HIV research, the Medal of Honor from the Aix Marseille University and the French National Institute for Intellectual Properties Award (Institut National de la Propriété Industrielle). He is the director of a CNRS lab entitled “Etude de Tat et Recherches Appliquées sur le VIH-1” (ETRAV) located in the faculty of Pharmacy at Marseille. ETRAV is the only lab working on AIDS in Aix Marseille University. He is member of the Editorial Board of scientific journals. He is author and co author of 55 scientific publications referenced in PUBMED (two are in press), most of them having a high impact factor (PNAS, EMBO, JBC, RETROVIROLOGY etc …) and five international patents (PCT) on active compounds against the HIV-1 Tat. His main field of interest is related to the HIV-1 Tat proteins and he is the coordinator of a Phase I/II clinical trial of a vaccine targeting Tat at Marseille that began in 2013.
Abstract
Abstract : HIV Extracellular Tat: Myth or Reality?
